Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this study is to determine the progression-free survival and objective response rate (complete + partial responses) of subjects with stage IIIB with pleural effusion or IV non-small cell lung cancer treated with paclitaxel and carboplatin plus either tamibarotene or matching placebo.
Critère d'inclusion
- Advanced non-small-cell lung cancer